Psyllid ID: psy17199
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 182 | ||||||
| 328698045 | 1098 | PREDICTED: hypothetical protein LOC10057 | 0.576 | 0.095 | 0.661 | 5e-38 | |
| 347967429 | 942 | AGAP002229-PA [Anopheles gambiae str. PE | 0.714 | 0.138 | 0.582 | 2e-37 | |
| 340719998 | 741 | PREDICTED: 5-hydroxytryptamine receptor | 0.423 | 0.103 | 0.819 | 5e-36 | |
| 270008194 | 700 | hypothetical protein TcasGA2_TC013982 [T | 0.423 | 0.11 | 0.831 | 1e-35 | |
| 195395979 | 926 | GJ10131 [Drosophila virilis] gi|19414332 | 0.560 | 0.110 | 0.663 | 2e-35 | |
| 195111751 | 942 | GI22528 [Drosophila mojavensis] gi|19391 | 0.560 | 0.108 | 0.663 | 2e-35 | |
| 350408117 | 736 | PREDICTED: hypothetical protein LOC10074 | 0.423 | 0.104 | 0.819 | 2e-35 | |
| 442617996 | 947 | CG42796, isoform E [Drosophila melanogas | 0.560 | 0.107 | 0.663 | 2e-35 | |
| 320542529 | 904 | CG42796, isoform D [Drosophila melanogas | 0.560 | 0.112 | 0.663 | 2e-35 | |
| 198453018 | 918 | GA20762 [Drosophila pseudoobscura pseudo | 0.560 | 0.111 | 0.663 | 2e-35 |
| >gi|328698045|ref|XP_003240524.1| PREDICTED: hypothetical protein LOC100575043 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 162 bits (410), Expect = 5e-38, Method: Composition-based stats.
Identities = 78/118 (66%), Positives = 91/118 (77%), Gaps = 13/118 (11%)
Query: 32 QVPLCCLPGY-----FPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGR 86
Q+P+ PG+ FP PVYCL WICLDVLFCTASIMHLCTISVDRYLSL+YP+KFGR
Sbjct: 300 QLPIKKSPGHDLIREFPFAPVYCLAWICLDVLFCTASIMHLCTISVDRYLSLRYPMKFGR 359
Query: 87 NKTRKRVILKIAFVWLLSVAMSLPLSLMYSQVIQLLHLDFGLIMILGYFPLP-PVYCL 143
NKTR+RVILKI FVWLLS+AMSLPLSLMYS+ DF +++ G +P P+Y L
Sbjct: 360 NKTRRRVILKIVFVWLLSIAMSLPLSLMYSK-------DFNSVLVNGSCQIPDPLYKL 410
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967429|ref|XP_001687830.2| AGAP002229-PA [Anopheles gambiae str. PEST] gi|333466300|gb|EDO64817.2| AGAP002229-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
| >gi|340719998|ref|XP_003398431.1| PREDICTED: 5-hydroxytryptamine receptor 1A-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
| >gi|270008194|gb|EFA04642.1| hypothetical protein TcasGA2_TC013982 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|195395979|ref|XP_002056611.1| GJ10131 [Drosophila virilis] gi|194143320|gb|EDW59723.1| GJ10131 [Drosophila virilis] | Back alignment and taxonomy information |
|---|
| >gi|195111751|ref|XP_002000441.1| GI22528 [Drosophila mojavensis] gi|193917035|gb|EDW15902.1| GI22528 [Drosophila mojavensis] | Back alignment and taxonomy information |
|---|
| >gi|350408117|ref|XP_003488309.1| PREDICTED: hypothetical protein LOC100748213 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
| >gi|442617996|ref|NP_001262373.1| CG42796, isoform E [Drosophila melanogaster] gi|440217199|gb|AGB95755.1| CG42796, isoform E [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
| >gi|320542529|ref|NP_649806.2| CG42796, isoform D [Drosophila melanogaster] gi|318068736|gb|AAN13390.2| CG42796, isoform D [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
| >gi|198453018|ref|XP_001359030.2| GA20762 [Drosophila pseudoobscura pseudoobscura] gi|198132179|gb|EAL28173.2| GA20762 [Drosophila pseudoobscura pseudoobscura] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 182 | ||||||
| FB|FBgn0261929 | 778 | CG42796 [Drosophila melanogast | 0.532 | 0.124 | 0.685 | 2.1e-33 | |
| UNIPROTKB|Q50DZ8 | 434 | 5HT2B "Uncharacterized protein | 0.395 | 0.165 | 0.5 | 3.8e-18 | |
| UNIPROTKB|F1RWT6 | 351 | HTR2C "Uncharacterized protein | 0.439 | 0.227 | 0.506 | 5.6e-18 | |
| UNIPROTKB|Q8UUG8 | 471 | htr2b "5-hydroxytryptamine rec | 0.395 | 0.152 | 0.527 | 3.1e-17 | |
| ZFIN|ZDB-GENE-120215-109 | 355 | htr2cl2 "5-hydroxytryptamine ( | 0.489 | 0.250 | 0.415 | 1.5e-16 | |
| UNIPROTKB|J9PBP0 | 458 | HTR2C "5-hydroxytryptamine rec | 0.439 | 0.174 | 0.493 | 1.7e-16 | |
| UNIPROTKB|P28335 | 458 | HTR2C "5-hydroxytryptamine rec | 0.439 | 0.174 | 0.493 | 1.7e-16 | |
| MGI|MGI:96281 | 459 | Htr2c "5-hydroxytryptamine (se | 0.439 | 0.174 | 0.493 | 1.7e-16 | |
| RGD|2848 | 460 | Htr2c "5-hydroxytryptamine (se | 0.439 | 0.173 | 0.493 | 1.7e-16 | |
| ZFIN|ZDB-GENE-081104-48 | 518 | htr2cl1 "5-hydroxytryptamine ( | 0.598 | 0.210 | 0.398 | 1.7e-16 |
| FB|FBgn0261929 CG42796 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 363 (132.8 bits), Expect = 2.1e-33, Sum P(2) = 2.1e-33
Identities = 72/105 (68%), Positives = 84/105 (80%)
Query: 40 GYFPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGRNKTRKRVILKIAF 99
GYFPL +CLTWICLDVLFCTASIMHLCTISVDRYLSL+YP++FGRNKTR+RV LKI F
Sbjct: 11 GYFPLGSEHCLTWICLDVLFCTASIMHLCTISVDRYLSLRYPMRFGRNKTRRRVTLKIVF 70
Query: 100 VWLLSVAMSLPLSLMYSQVIQLLHLDFGLIMILGYFPLP-PVYCL 143
VWLLS+AMSLPLSLMYS+ + +++ G +P PVY L
Sbjct: 71 VWLLSIAMSLPLSLMYSK-------NHASVLVNGTCQIPDPVYKL 108
|
|
| UNIPROTKB|Q50DZ8 5HT2B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1RWT6 HTR2C "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q8UUG8 htr2b "5-hydroxytryptamine receptor 2B" [Tetraodon fluviatilis (taxid:47145)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-120215-109 htr2cl2 "5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled-like 2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|J9PBP0 HTR2C "5-hydroxytryptamine receptor 2C" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P28335 HTR2C "5-hydroxytryptamine receptor 2C" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| MGI|MGI:96281 Htr2c "5-hydroxytryptamine (serotonin) receptor 2C" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
| RGD|2848 Htr2c "5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-081104-48 htr2cl1 "5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled-like 1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 182 | |||
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 2e-13 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 7e-07 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-13
Identities = 27/78 (34%), Positives = 44/78 (56%)
Query: 40 GYFPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGRNKTRKRVILKIAF 99
G +P C L V+ ASI+ L IS+DRYL++ +P+++ R +T +R + I
Sbjct: 42 GDWPFGDALCKLVGFLFVVNGYASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILV 101
Query: 100 VWLLSVAMSLPLSLMYSQ 117
VW+L++ +SLP L
Sbjct: 102 VWVLALLLSLPPLLFSWL 119
|
This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 182 | |||
| KOG4219|consensus | 423 | 99.75 | ||
| KOG4220|consensus | 503 | 99.7 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 99.69 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 99.62 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 99.62 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 99.55 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 99.55 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 99.51 | |
| KOG4220|consensus | 503 | 99.11 | ||
| KOG2087|consensus | 363 | 98.9 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 98.77 | |
| KOG4219|consensus | 423 | 98.56 | ||
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 98.55 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 98.52 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 98.29 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 98.28 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 98.13 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 98.05 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 97.8 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 97.76 | |
| PF11710 | 201 | Git3: G protein-coupled glucose receptor regulatin | 97.17 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 96.88 | |
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 96.81 | |
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 95.63 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 94.29 | |
| KOG2087|consensus | 363 | 94.12 | ||
| PF10317 | 292 | 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept | 81.81 |
| >KOG4219|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=135.66 Aligned_cols=106 Identities=19% Similarity=0.324 Sum_probs=96.1
Q ss_pred chhhHhHHHHHHHHHHHHHhhhhhh---ccccccccccchhHHhHHHHHHHHHHHHHHHHHHHhhhheeeccccccccee
Q psy17199 13 HLFIIFTHLQLLHFLLCHFQVPLCC---LPGYFPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGRNKT 89 (182)
Q Consensus 13 ~~n~~l~~La~~Dl~~~~~~~p~~~---~~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~iav~Ry~ai~~pl~~~~~~t 89 (182)
-+|+|+.|||+||+..+.+..|+.. +...|.+|+..|++..++....+.+|+++++++|+|||.||.||++.+ .+
T Consensus 69 vtnyfL~NLAfADl~~s~Fn~~f~f~yal~~~W~~G~f~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl~~r--~s 146 (423)
T KOG4219|consen 69 VTNYFLVNLAFADLSMSIFNTVFNFQYALHQEWYFGSFYCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPLQPR--PS 146 (423)
T ss_pred hHHHHHHHHHHHHHHHHHHhhHHHHHHHHHhccccccceeeeccccchhhhhHhHHHHHHHHHHHHHHHhhhcccC--CC
Confidence 4799999999999999999999974 367899999999999999999999999999999999999999999864 88
Q ss_pred cceeeeeehHhHHHHHHHHhhhHhhccceee
Q psy17199 90 RKRVILKIAFVWLLSVAMSLPLSLMYSQVIQ 120 (182)
Q Consensus 90 ~~~~~~~l~~~wi~s~~~~~p~~~~~~~~~~ 120 (182)
++...+.+..+|+++++++.|..+.....+.
T Consensus 147 ~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~ 177 (423)
T KOG4219|consen 147 RRSSKIIILLIWALALLLALPQLLYSSVEEL 177 (423)
T ss_pred CcceeehhHHHHHHHHHHhccceeeeeeEEe
Confidence 8888999999999999999998777665443
|
|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >KOG4219|consensus | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 182 | ||||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 8e-09 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 4e-06 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 1e-08 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 1e-04 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 1e-06 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 8e-05 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 1e-06 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 8e-05 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 2e-06 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 3e-06 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 6e-04 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 4e-06 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 7e-04 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 4e-06 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 5e-04 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 4e-06 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 6e-04 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 5e-06 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 6e-04 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 7e-06 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 5e-04 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 7e-06 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 5e-04 | ||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 8e-06 | ||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 5e-04 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 9e-06 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 8e-04 | ||
| 4dkl_A | 464 | Crystal Structure Of The Mu-Opioid Receptor Bound T | 1e-04 | ||
| 3rze_A | 452 | Structure Of The Human Histamine H1 Receptor In Com | 2e-04 | ||
| 4ea3_B | 434 | Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI | 3e-04 |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
|
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 | Back alignment and structure |
| >pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 | Back alignment and structure |
| >pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 182 | |||
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 5e-26 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 5e-17 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 9e-25 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 2e-16 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 1e-24 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 2e-15 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 1e-24 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 9e-16 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 7e-24 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 1e-15 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 7e-24 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 3e-15 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 2e-22 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 1e-14 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 3e-18 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 2e-11 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 4e-17 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 5e-11 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-10 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-04 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 1e-10 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 7e-04 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 1e-08 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 3e-06 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 1e-08 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 2e-08 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 3e-08 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 2e-07 |
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 22/76 (28%), Positives = 37/76 (48%)
Query: 40 GYFPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGRNKTRKRVILKIAF 99
F CL C ++ +SI L I++DRY++++ P+++ T R IA
Sbjct: 83 TGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAI 142
Query: 100 VWLLSVAMSLPLSLMY 115
W+LS A+ L L +
Sbjct: 143 CWVLSFAIGLTPMLGW 158
|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Length = 32 | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Length = 32 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 182 | |||
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 99.78 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 99.69 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 99.67 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 99.67 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 99.66 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 99.65 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 99.65 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 99.65 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 99.65 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 99.64 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 99.64 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 99.63 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 99.62 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 99.62 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 99.61 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 99.58 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 99.58 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 99.55 | |
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 98.91 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 98.86 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 98.78 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 98.76 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 98.71 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 98.68 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 98.67 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 98.63 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 98.61 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 98.59 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 98.57 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 98.56 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.55 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 98.54 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 98.54 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 98.53 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 98.52 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 98.52 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 98.47 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.11 |
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.4e-20 Score=150.94 Aligned_cols=108 Identities=19% Similarity=0.301 Sum_probs=98.8
Q ss_pred cchhhHhHHHHHHHHHHHHHhhhhhhc-----cccccccccchhHHhHHHHHHHHHHHHHHHHHHHhhhheeeccccccc
Q psy17199 12 DHLFIIFTHLQLLHFLLCHFQVPLCCL-----PGYFPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGR 86 (182)
Q Consensus 12 ~~~n~~l~~La~~Dl~~~~~~~p~~~~-----~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~iav~Ry~ai~~pl~~~~ 86 (182)
+..|+|++|||++|++++++.+|+.+. .+.|.+|+..|++..++..+...+|++++++|++|||.||++|+++++
T Consensus 68 ~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~g~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~ 147 (510)
T 4grv_A 68 STVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAFGDAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKT 147 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCC
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccc
Confidence 356999999999999999999998753 467999999999999999999999999999999999999999999999
Q ss_pred ceecceeeeeehHhHHHHHHHHhhhHhhcccee
Q psy17199 87 NKTRKRVILKIAFVWLLSVAMSLPLSLMYSQVI 119 (182)
Q Consensus 87 ~~t~~~~~~~l~~~wi~s~~~~~p~~~~~~~~~ 119 (182)
.+|++++...++++|++++++++|+.+.+....
T Consensus 148 ~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~ 180 (510)
T 4grv_A 148 LMSRSRTKKFISAIWLASALLAIPMLFTMGLQN 180 (510)
T ss_dssp CCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEE
T ss_pred cccccccceeehHHHHHHHHHHHHHHHhhcccc
Confidence 999999999999999999999999988776443
|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
No hit with e-value below 0.005
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 182 | |||
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 99.39 | |
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 97.99 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.39 E-value=8e-14 Score=107.05 Aligned_cols=108 Identities=20% Similarity=0.338 Sum_probs=90.3
Q ss_pred cchhhHhHHHHHHHHHHHHHhhhhhhc---cccccccccchhHHhHHHHHHHHHHHHHHHHHHHhhhheeecccccccce
Q psy17199 12 DHLFIIFTHLQLLHFLLCHFQVPLCCL---PGYFPLPPVYCLTWICLDVLFCTASIMHLCTISVDRYLSLKYPIKFGRNK 88 (182)
Q Consensus 12 ~~~n~~l~~La~~Dl~~~~~~~p~~~~---~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~iav~Ry~ai~~pl~~~~~~ 88 (182)
+..|+++.|||++|++.++...|..+. .+.|..+...|+...+.......++.++++++++|||.++++|++++..
T Consensus 70 ~~~~~~l~nLaiaDll~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~~- 148 (348)
T d1u19a_ 70 TPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRF- 148 (348)
T ss_dssp SHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSCTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCCC-
T ss_pred CHhHHHHHHHHHHHHHHHHHHHHHhhhhhccCccccCchhhhhhhhccccceeeecchhhhhhcccceeeecccccccc-
Confidence 467999999999999999888887653 5678888999999999999999999999999999999999999998654
Q ss_pred ecceeeeeehHhHHHHHHHHhhhHhhccceee
Q psy17199 89 TRKRVILKIAFVWLLSVAMSLPLSLMYSQVIQ 120 (182)
Q Consensus 89 t~~~~~~~l~~~wi~s~~~~~p~~~~~~~~~~ 120 (182)
++++.......+|..+.....|+.+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (348)
T d1u19a_ 149 GENHAIMGVAFTWVMALACAAPPLVGWSRYIP 180 (348)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEE
T ss_pred ccccccccceeeehhhhheecccccccceecc
Confidence 55566667777888888888887776655443
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|